Dr Reddy's Laboratories Limited has recalled 17,548 1000-count bottles of Tizanidine Tablets USP (4 mg), a prescription medication used as a muscle relaxant. This recall was initiated after the tablets failed dissolution testing during a 24-month long-term stability study, which means the medication may not break down properly in the body as intended. Consumers who are currently taking this medication should consult with their healthcare provider or pharmacist regarding the recall.
When a medication fails dissolution specifications, it may not be absorbed correctly by the body, which can lead to the drug being less effective than required. No specific injuries or adverse health events have been reported in connection with this recall.
You have 2 options:
Manufactured by Dr. Reddy's Laboratories Limited Srikakulam - 532 409 India.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.